1. Ishihara J et al. "Demographics, lifestyles, health characteristics, and dietary intake among dietary supplements users in Japan." Int J Epidemiol. 32, 4:546-53, 2003.

2. Najm W et al. "Use of complementary and alternative medicine among the ethnic elderly." Altern Ther Health Med. 9, 3:50-7, 2003.

3. Gillberg P et al. "Two years of treatment with recombinant human growth hormone increases bone mineral density in men with idiopathic osteoporosis." J Clin Endocrinol Metab. 87, 11:4900-6, 2002.

4. Gilchrist FJ et al. "The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults." Clin Endocrinol (Oxf). 57, 3:363-70, 2002.

5. Mesa J et al. "[Growth hormone deficiency in adults: effects of replacement therapy on body composition and health-related quality of life.]" (Article in Spanish.) Med Clin (Barc). 120, 2:41-6, 2003.

6. Shadid S, Jensen MD. "Effects of growth hormone administration in human obesity." Obes Res. 11, 2:170-5, 2003.

7. Bramnert M et al. "Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle." J Clin Endocrinol Metab. 88, 4:1455-63, 2003.

8. Brewitt B et al. "Homeopathic human growth hormone for physiologic and psychological health." Alt Comp Ther. 5, 6:373-85, 1999.

9. Chromiak JA, Antonio J. "Use of amino acids as growth hormone-releasing agents by athletes." Nutrition. 18, 7-8:657-61, 2002.

10. Colombani PC et al. "Chronic arginine aspartate supplementation in runners reduces total plasma amino acid level at rest and during a marathon run." Eur J Nutr. 38, 6:263-70, 1999.

11. di Luigi L et al. "Acute amino acids supplementation enhances pituitary responsiveness in athletes." Med Sci Sports Exerc. 31, 12:1748-54, 1999.

12. Fogelholm GM et al. "Low-dose amino acid supplementation: no effects on serum human growth hormone and insulin in male weightlifters." Int J Sport Nutr. 3, 3:290-7, 1993.

13. Celec P, Starka L. "Dehydroepiandrosterone - is the fountain of youth drying out?" Physiol Res. 52, 4:397-407, 2003.

14. Aoki K et al. "Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone." J Steroid Biochem Mol Biol. 85, 2-5:469-72, 2003.

15. Dhatariya KK, Nair KS. "Dehydroepiandrosterone: is there a role for replacement?" Mayo Clin Proc. 78, 10:1257-73, 2003.

16. Rhoden EL et al. "Effects of chronic administration of dehydroepiandrosterone on serum testosterone levels and prostatic tissue in rats." J Urol. 170, 5:2101-3, 2003.

17. Kawano H et al. "Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men." J Clin Endocrinol Metab. 88, 7:3190-5, 2003.

18. Buvat J. "Androgen therapy with dehydroepiandrosterone." World J Urol. Oct. 10 e-publication ahead of print.

19. Pierpaoli W et al. "Circadian melatonin and young-to-old pineal grafting postpone aging and maintain juvenile conditions of reproductive functions in mice and rats." Exp Gerontol. 32, 4-5:587-602, 1997.

20. Bulian D, Pierpaoli W. "The pineal gland and cancer. I. Pinealectomy corrects congenital hormonal dysfunctions and prolongs life of cancer-prone C3H/He mice." J Neroimmunol. 108, 1-2:131-5, 2000.

21. Bellipanni G et al. "Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study." Exp Gerontol. 36, 2:297-310, 2001.

22. Watanabe Y. "[Neural and molecular mechanisms of fatigue and recovery from fatigue.]" (Article in Japanese.) Nihon Shinkei Seishin Yakurigaku Zasshi. 23, 3:149-53, 2003.

23. Thompson D et al. "Prolonged vitamin C supplementation and recovery from demanding exercise." Int J Sport Nutr Exerc Metab. 11, 4:466-81, 2001.

24. Asha Devi S et al. "Dietary vitamin E and physical exercise: I. Altered endurance capacity and plasma lipid profile in ageing rats." Exp Gerontol. 28, 3:285-90, 2003.

25. Coombes JS et al. "Effects of vitamin E deficiency on fatigue and muscle contractile properties." Eur J Appl Physiol. 87, 3:272-7, 2002.

26. Huang HY, Appel LJ. "Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans." J Nutr. 133, 10:3137-40, 2003.

27. Werback MR. "Nutritional strategies for treating chronic fatigue syndrome." Altern Med Rev. 5, 2:93-108, 2000.

28. Gaby AR. "Intravenous nutrient therapy: the 'Myer's cocktail.'" Altern Med Rev. 7, 5:389-403, 2002.

29. Crestanello JA et al. 'Effect of coenzyme Q10 supplementation on mitochondrial function after myocardial ischemia reperfusion." J Surg Res. 102, 2:221-8, 2002.

30. Hughes K et al. "Coenzyme Q10 and differences in coronary heart disease risk in Asian Indians and Chinese." Free Radic Biol Med. 32, 2:132-8, 2002.

31. Kwong LK et al. "Effects of coenzyme Q(10) administration on tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat." Free Radic Biol Med. 33, 5:627-38, 2002.

32. Kitts D, Hu C. "Efficacy and safety of ginseng." Public Health Nutr. 3, 4A:473-85, 2000.

33. Coleman CI et al. "The effects of Panax ginseng on quality of life." J Clin Pharm Ther. 28, 1:5-15, 2003.

34. Wiklund IK et al. "Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group." Int J Clin Pharmacol Res. 19, 3:89-99, 1999.

35. Ellis JM, Reddy P. "Effects of Panax ginseng on quality of life." Ann Pharmacother. 36, 3:375-9, 2002.

36. Wesnes KA et al. "The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers." Psychopharmacology (Berl). 152, 4:353-61, 2000.

37. Hoyer S et al. "Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761)." J Neural Transm. 106, 11-12:1171-88, 1999.

38. Eckert A et al. "Effects of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress." Pharmacopsychiatry. 36 Supple 1:S15-23, 2003.

39. Cockle SM et al. "The effects of Ginkgo biloba extract (LI 1370) supplementation on activities of daily living in free living older volunteers: a questionnaire survey." Hum Psychopharmacol. 15, 4:227-35, 2000.

40. Birks J et al. "Ginkgo biloba for cognitive impairment and dementia." Cochrane Database Syst Rev. 4:CD003120, 2002.

41. Perry IJ. "Healthy diet and lifestyle clustering and glucose intolerance." Proc Nutr Soc. 61, 4:543-51, 2002.

42. Kim DS et al. "Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body weight in dexamethasone-treated rats." Metabolism. 51, 5:589-94, 2002.

43. Appleton DJ et al. "Dietary chromium tripicolinate supplementation reduces glucose concentrations and improves glucose tolerance in normal-weight cats." J Feline Med Surg. 4, 1:13-25, 2002.

44. Cefalu WT et al. "Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats." J Nutr. 132, 6:1107-14, 2002.

45. Althuis MD et al. "Glucose and insulin responses to dietary chromium supplements: a meta-analysis." Am J Clin Nutr. 76, 1:148-55, 2002.

46. Amato P et al. "Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women." J Gerontol A Biol Sci Med Sci. 55, 5:M260-3, 2000.

47. Preuss HG et al. "Protective effects of a novel niacin-bound chromium complex and a grapeseed proanthocyanidin extract on advancing age and various aspects of syndrome X." Ann N Y Acad Sci. 957:250-9, 2002.

48. Preuss HG et al. "Long-term effects of chromium, grape seed extract, and zinc on various metabolic parameters of rats." Mol Cell Biochem. 223, 1-2:95-102, 2001.

49. Kelly GS. "Insulin resistance: lifestyle and nutritional interventions." Altern Med Rev. 5, 2:109-32, 2000.

50. Gupta A et al. "Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study." J Assoc Pysicians India. 49:1057-61, 2001.

51. Yeh GY et al. "Systematic review of herbs and dietary supplements for glycemic control in diabetes." Diabetes Care. 26, 4:1277-94, 2003.

52. Xie JT et al. "Anti-diabetic effects of Gymnema yunnanense extract." Pharmacol Res. 47, 4:323-9, 2003.

53. Nagao K et al. "Conjugated linoleic acid enhances plasma adiponectin level and alleviates hyperinsulinemia and hypertension in Zucker diabetic fatty (fa/fa) rats." Biochem Biophys Res Commun. 310, 2:562-6, 2003.

54. Teachey MK et al. "Interactions of conjugated linoleic acid and lipoic acid on insulin action in the obese Zucker rat." Metabolism. 52, 9:1167-74, 2003.

55. Hargrave KM et al. "Conjugated linoleic acid does not improve insulin tolerance in mice." Obes Res. 11, 9:1104-15, 2003.

56. Kelley DS, Erickson KL. "Modulation of body composition and immune cell functions by conjugated linoleic acid in humans and animal models: benefits vs. risks." Lipids. 38, 4:377-86, 2003.

57. Ramadass P et al. "Dietary flavonoids modulate PCB-induced oxidative stress, CYP1A1 induction and AhR-DNA binding activity in vascular endothelial cells." Toxicol Sci. Sept. 11 e-pub ahead of print.

58. Hofmann CS, Sonenshein GE. "Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53." FASEB J. 17, 6:702-4, 2003.

59. Ahn WS et al. "Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions." Eur J Cancer Prev. 12, 5:383-90, 2003.

60. Ahn WS et al. "A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression." DNA Cell Biol. 22, 3:217-24, 2003.

61. Yeh CW et al. "Suppression of fatty acid synthase in MCF-7 breast cancer cells by tea and tea polyphenols: a possible mechanism for their hyperlipidemic effects." Pharmacogenomics J. E-pub ahead of print Aug. 19.

62. Brusselmans K et al. "Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells." Int J Cancer. 106, 6:856-62, 2003.

63. Kemberling JK et al. "Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate." J Urol. 170, 3:773-6, 2003.

64. Chen C et al. "Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells." Carcinogenesis. 24, 8:1369-78, 2003.

65. Chung JH et al. "Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes." FASEB J. 17, 13:1913-5, 2003.

66. Yamamoto T et al. "Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells." J Pharmacol Exp Ther. 307, 1:230-6, 2003.

67. Visioli F et al. "Hydroxytyrosol, as a component of olive mill waste water, is dose-dependently absorbed and increases the antioxidant capacity of rat plasma." Free Radic Res. 34, 3:301-5, 2001.

68. Visioli F et al. "Olive polyphenol hydroxytyrosol prevents passive smoking-induced oxidative stress." Circulation. 102:2169-71, 2000.

69. Carluccio MA et al. "Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals." Arterioscler Thromb Vasc Biol. 23, 4:622-9, 2003.